MedPath

The effect of cardiac rehabilitation on reverse cholesterol transport

Not Applicable
Conditions
Atherosclerosis.
Atherosclerotic heart disease
Registration Number
IRCT2016050827803N1
Lead Sponsor
-
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
23
Inclusion Criteria

Coronary artery male patients (Atherosclerosis) without any training experience.
Exclusion criteria: Coronary artery male patients (Atherosclerosis) that cannot participate in 8-week moderate resistance training or do not have regular participation in exercise.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Apolipoprotein A1. Timepoint: 48 hours before intervention and two months after intervention. Method of measurement: ELISA Test.;ATP-binding cassette transporter A1 (ABCA1) Gene. Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Polymerase chain reaction (PCR) Method.;High-density lipoprotein (HDL). Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Colorimetric Method.;Low-density lipoprotein (LDL). Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Colorimetric Method.;Heart function. Timepoint: 48 hours before intervention and two month after intervention. Method of measurement: Echocardiography.
Secondary Outcome Measures
NameTimeMethod
-. Timepoint: -. Method of measurement: -.
© Copyright 2025. All Rights Reserved by MedPath